Source:http://linkedlifedata.com/resource/pubmed/id/17181651
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0019169,
umls-concept:C0023911,
umls-concept:C0035015,
umls-concept:C0205462,
umls-concept:C0205474,
umls-concept:C0348050,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0745744,
umls-concept:C1548437,
umls-concept:C1552599,
umls-concept:C1704258,
umls-concept:C1704787,
umls-concept:C1882923,
umls-concept:C2826293
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-12-21
|
pubmed:abstractText |
There is no agreement regarding the treatment of early allograft rejection (EAR) in adult living donor liver transplantation (LDLT). A protocol biopsy was performed in 62 adult LDLT recipients. Twenty-one patients (33.9%) had histological evidence of EAR. Of these, 14 patients had biochemical abnormalities and seven patients had no associated biochemical abnormalities. None of the seven patients with subclinical EAR (11.3% of the entire study population) were treated, and no subsequent rejection was observed. Gender mismatch (female-to-male) was the single independent risk factor for histological EAR [odds ratio (OR) = 13.458; 95% confidence interval (CI), 1.836-98.649] and the cumulative probability for a subsequent rejection was higher in patients with EAR (OR = 11.085; 95% CI, 1.221-100.654). However, the actuarial 1 year patient and graft survival rate in patients with EAR (81.0% and 85.5%) were similar to those without EAR (92.7% and 97.25%; P = 0.127 and 0.302, respectively). The presence of an initial biochemical abnormality was an independent risk factor for both a decreased patient survival (OR = 5.827; 95% CI, 1.095-31.017; P = 0.039) and graft loss (OR = 20.646; 95% CI, 2.044-208.524; P = 0.010). Subsequent rejection developed more frequently in patients with EAR. However, the survival is not determined by the presence of EAR but by the presence of a biochemical abnormality.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0934-0874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-44
|
pubmed:meshHeading |
pubmed-meshheading:17181651-Adult,
pubmed-meshheading:17181651-Biopsy,
pubmed-meshheading:17181651-Female,
pubmed-meshheading:17181651-Graft Rejection,
pubmed-meshheading:17181651-Graft Survival,
pubmed-meshheading:17181651-Hepatitis B,
pubmed-meshheading:17181651-Humans,
pubmed-meshheading:17181651-Immunosuppressive Agents,
pubmed-meshheading:17181651-Liver Failure, Acute,
pubmed-meshheading:17181651-Liver Transplantation,
pubmed-meshheading:17181651-Living Donors,
pubmed-meshheading:17181651-Male,
pubmed-meshheading:17181651-Middle Aged,
pubmed-meshheading:17181651-Survival Analysis
|
pubmed:year |
2007
|
pubmed:articleTitle |
The clinical significance of early histological rejection with or without biochemical abnormality in adult living donor liver transplantation for hepatitis B virus related end stage liver disease.
|
pubmed:affiliation |
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
|
pubmed:publicationType |
Journal Article
|